Concomitant AID Expression and BCL7A Loss Associates With Accelerated Phase Progression and Imatinib Resistance in Chronic Myeloid Leukemia.
10.3343/alm.2017.37.2.177
- Author:
Nae YU
1
;
Saeam SHIN
;
Jong Rak CHOI
;
Yoonjung KIM
;
Kyung A LEE
Author Information
1. Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea. KAL1119@yuhs.ac
- Publication Type:Brief Communication ; Case Reports ; Letter
- MeSH:
Aged;
Cytidine Deaminase/*genetics/metabolism;
Dasatinib/therapeutic use;
Disease Progression;
Drug Resistance, Neoplasm;
Fusion Proteins, bcr-abl/genetics/metabolism;
Humans;
Imatinib Mesylate/*therapeutic use;
In Situ Hybridization, Fluorescence;
Karyotype;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*drug therapy;
Male;
Microfilament Proteins/*genetics/metabolism;
Oncogene Proteins/*genetics/metabolism;
Protein Kinase Inhibitors/*therapeutic use
- From:Annals of Laboratory Medicine
2017;37(2):177-179
- CountryRepublic of Korea
- Language:English
-
Abstract:
No abstract available.
